Zeenews BureauNew Delhi: French pharmaceutical company Sanofi is conducting a key trial to prevent an estimated 100 million cases of dengue infection each year.The tropical killer is spread by the bite of the Aedes aegypti mosquito. It is also known as “breakbone fever” and can cause intense joint and muscle pain. Though dengue and malaria are both transmitted by mosquitoes, they are notably different diseases. Malaria typically attacks rural populations living near swamps. Dengue, by contrast, has adapted to life in the city.
Narendra Modi flies to Brazil for BRICS Summit
Dilip Kumar`s ancestral home declared national heritage in Pak
Govt prepares list of five governors for Raj Bhawans
UPSC aspirants protest outside Rajnath Singh`s residence